跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Azacitidine/Lenalidomide
首页
药物
Azacitidine/Lenalidomide
Azacitidine/Lenalidomide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
申请人: ZELDIS JEROME B
优先权: 2010
CN
EP
US
6 件公开
METHODS OF TREATING ANEMIA USING FORMOTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
申请人: DANA FARBER CANCER INST INC
优先权: 2022
CN
EP
US
WO
5 件公开
Non-aqueous chemotherapeutic suspensions for oral dosage
申请人: ONCOSOL LTD
优先权: 2018
CN
US
2 件公开
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
申请人: CELGENE CORP
优先权: 2019
US
METHODS FOR TREATING AML-MRC AND MDS
申请人: ASCENTAGE PHARMA SUZHOU CO LTD
优先权: 2022
US
Pharmaceutical composition containing phosphoinositide 3-kinase inhibitor
申请人: TONGRUN BIOLOGICAL MEDICINE SHANGHAI CO LTD
优先权: 2022
CN
THE COMBINATION OF TRX-E-002-1 WITH A BCL-2 INHIBITOR OR A HYPOMETHYLATING AGENT IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA
申请人: VIVESTO AB
优先权: 2024
WO
药物
反馈